Showing results (41-50 of 201) with videos related to

Sort By:
Pageof 21
Leukemia & Lymphoma|April 8, 2021
Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry dataIvan Pasic, Kristjan Paulson, Graham Dozois, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendationsTong Zhang, Sylvie Grenier, Bevoline Nwachukwu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 31, 2002
Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liverAndrew S Daly, Wanda S Hasegawa, Jeffrey H Lipton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2018
Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort studyGerald M Devins, Kenneth Mah, Hans A Messner, et al.
Leukemia & Lymphoma|August 9, 2023
High sensitivity c-reactive protein and circulating biomarkers of endothelial dysfunction in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitorsNazanin Aghel, Dakota Gustafson, Diego Delgado, et al.
American Journal of Hematology|March 13, 2014
BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phaseDennis Dong Hwan Kim, Nada Hamad, Hong Gi Lee, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|February 12, 2022
Evaluation of a group-based exercise and relaxation rehabilitation program during hospitalization for allogeneic hematopoietic stem cell transplantEncarna Camacho Pérez, Samantha Mayo, Jeffrey H Lipton, et al.
European Journal of Haematology|November 4, 2024
Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell TransplantationNihar Desai, Auro Viswabandya, Dennis Dong Hwan Kim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 12, 2009
Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body sizeLakshmi Sriharsha, Jeffrey H Lipton, Greg Pond, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2012
Incidence and risk factors for early hepatotoxicity and its impact on survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantationKit Man Wong, Eshetu G Atenafu, Dennis Kim, et al.
Pageof 21